Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us

Acute care genomics

Home Research we’re supporting Acute care genomics

The Acute Care Genomics study has pioneered a national approach to delivering ultra-rapid genomic testing for babies and children admitted to intensive care with suspected genetic conditions, coupled with a comprehensive economic, implementation and psychosocial evaluation.

Established in 2018, the study set out to build a network of hospitals, diagnostic laboratories, and multi-disciplinary teams of medical and genomic specialists to deliver timely and accurate answers for families with babies and children in intensive care.

Ultra-rapid genomic testing (with less than a five-day turnaround) is only available at a handful of centres worldwide, and the Acute Care Genomics study is the first to provide rapid testing for rare disease diagnosis at a national level.

In its first phase, the study provided ultra-rapid genomic testing to more than 200 critically ill babies and children from across 12 Australian hospitals, with results available to most families in just three days. The study delivered a relatively high diagnostic rate of 53 per cent. Changes in clinical care occurred in 75 per cent of those children diagnosed, meaning fewer hospital days, fewer invasive procedures, and in some cases, access to life-saving treatments.

In July 2020, the Acute Care Genomics study team was granted $5 million in funding from the Australian Government’s Medical Research Future Fund (Genomics Health Futures Mission) to drive national expansion and transition to whole genome sequencing. Seventeen hospitals across Australia now participate in the program, including all children’s hospitals.

 

 

 

Lead investigators

Headshot of Professor Zornitza Stark

Professor Zornitza Stark

Victorian Clinical Genetic Services

A/Professor Sebastian Lunke

Victorian Clinical Genetic Services

Contact

Sophie Bouffler sophie.bouffler@mcri.edu.au


More research

Mother and child with heads together

Diagnosing neurological disorders

Graphic of kidneys with DNA in background

National Kidney Genomics Program

Couple's arms wrapped around stomach of woman

Genomic autopsy

Connect with us

(03) 9936 6345
info@australiangenomics.org.au
50 Flemington Road, Parkville
Victoria 3052 Australia

In the spirit of reconciliation Australian Genomics acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

To stay informed about our work, sign up to our newsletter

Subscribe

Quicklinks

  • Home
  • What we do
  • What we offer
  • Tools & resources
  • Our publications
  • Our project areas
  • Research we’re supporting
  • Our team

Privacy

  • We follow the Australian Privacy Principles
  • General privacy policy
  • Website privacy policies
  • Terms & conditions

Website by Blueboat.